Changes to Logistics, Medical Equipment, and Labor-Related Regulations
First written in FY2016. 14 of 15 entries say "Restated". Latest entry: FY2022-Q3.
No other company in this theme has enough history to compare yet.
- FY2022-Q3RestatedAnnual report
「During the cumulative third quarter under review, there were no significant changes in the matters described in this quarterly report regarding the business and accounting conditions that could materially affect investors’ decisions, or in the “Business and Other Risks” described in the securities report for the previous fiscal year.」
The company has disclosed that there have been no material changes in the risks associated with changes to logistics, medical device and labor-related regulations. - FY2022-Q2RestatedAnnual report
「During the cumulative second quarter under review, there were no significant changes in the matters described in this quarterly report regarding the business and accounting conditions that could materially affect investors’ decisions, or in the “Business and Other Risks” described in the securities report for the previous fiscal year.」
The company has disclosed that there have been no material changes in the risks associated with changes to logistics, medical device and labor-related regulations. - FY2021-Q3RestatedAnnual report
「During the cumulative third quarter under review, there were no significant changes in the matters described in this quarterly report regarding the business and accounting conditions that could materially affect investors’ decisions, or in the “Business and Other Risks” described in the securities report for the previous fiscal year.」
The company has disclosed that there have been no material changes in the risks associated with changes to logistics, medical device and labor-related regulations. - FY2021-Q2RestatedAnnual report
「During the cumulative second quarter under review, there were no significant changes in the matters described in this quarterly report regarding the business and accounting conditions that could materially affect investors’ decisions, or in the “Business and Other Risks” described in the securities report for the previous fiscal year.」
The company has disclosed that there have been no material changes in the risks associated with changes to logistics, medical device and labor-related regulations. - FY2021-Q1RestatedAnnual report
「During the first quarter of the current consolidated cumulative period, there were no occurrences of matters that could materially affect investors’ investment decisions among the matters relating to the business and financial position described in this quarterly report, nor were there any material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
The company has disclosed that there have been no material changes in the risks associated with changes to logistics, medical device and labor-related regulations. - FY2020-Q2RestatedAnnual report
「During the cumulative second quarter under review, there were no significant changes in the matters described in this quarterly report regarding the business and accounting conditions that could materially affect investors’ decisions, or in the “Business and Other Risks” described in the securities report for the previous fiscal year.」
The company has disclosed that there have been no material changes in the risks associated with changes to logistics, medical device and labor-related regulations. - FY2020-Q1RestatedAnnual report
「During the first quarter of the current consolidated cumulative period, there were no occurrences of matters that could materially affect investors’ investment decisions among the matters relating to the business and financial position described in this quarterly report, nor were there any material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
The company has disclosed that there have been no material changes in the risks associated with changes to logistics, medical device and labor-related regulations. - FY2019-Q3RestatedAnnual report
「During the cumulative third quarter under review, there were no significant changes in the matters described in this quarterly report regarding the business and accounting conditions that could materially affect investors’ decisions, or in the “Business and Other Risks” described in the securities report for the previous fiscal year.」
The company has disclosed that there have been no material changes in the risks associated with changes to logistics, medical device and labor-related regulations. - FY2019-Q2RestatedAnnual report
「During the cumulative second quarter under review, there were no significant changes in the matters described in this quarterly report regarding the business and accounting conditions that could materially affect investors’ decisions, or in the “Business and Other Risks” described in the securities report for the previous fiscal year.」
The company has disclosed that there have been no material changes in the risks associated with changes to logistics, medical device and labor-related regulations. - FY2019-Q1RestatedAnnual report
「During the first quarter of the current consolidated cumulative period, there were no occurrences of matters that could materially affect investors’ investment decisions among the matters relating to the business and financial position described in this quarterly report, nor were there any material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
The company has disclosed that there have been no material changes in the risks associated with changes to logistics, medical device and labor-related regulations. - FY2018-Q3RestatedAnnual report
「During the cumulative third quarter under review, there were no significant changes in the matters described in this quarterly report regarding the business and accounting conditions that could materially affect investors’ decisions, or in the “Business and Other Risks” described in the securities report for the previous fiscal year.」
The company has disclosed that there have been no material changes in the risks associated with changes to logistics, medical device and labor-related regulations. - FY2018-Q2RestatedAnnual report
「During the cumulative second quarter under review, there were no significant changes in the matters described in this quarterly report regarding the business and accounting conditions that could materially affect investors’ decisions, or in the “Business and Other Risks” described in the securities report for the previous fiscal year.」
The company has disclosed that there have been no material changes in the risks associated with changes to logistics, medical device and labor-related regulations. - FY2018-Q1RestatedAnnual report
「During the first quarter of the current consolidated cumulative period, there were no occurrences of matters that could materially affect investors’ investment decisions among the matters relating to the business and financial position described in this quarterly report, nor were there any material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
The company has disclosed that there have been no material changes in the risks associated with changes to logistics, medical device and labor-related regulations. - FY2017RestatedAnnual report
「The Group recognizes compliance-based management as its highest priority and is taking relevant measures, but depending on its business fields, it is subject to legal regulations including the Warehousing Business Act, Customs Business Act, Motor Truck Transportation Business Act, Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices, and Worker Dispatching Act.」
The risks of business restrictions resulting from changes in regulations governing logistics, customs clearance, transportation, medical devices and labor remain. - FY2016First statedAnnual report
「Depending on its business fields, the Group is subject to legal regulations including the Warehousing Business Act, Customs Business Act, Motor Truck Transportation Business Act, Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices, and Worker Dispatching Act.」
The disclosure states that regulatory revisions and changes in regulations relating to environmental issues may restrict some business activities.